MedPath

Elucidation of drug resistance mechanism at metastasis of liver cancer and bile duct cancer

Not Applicable
Recruiting
Conditions
iver cancer, Bile duct cancer
Registration Number
JPRN-UMIN000035090
Lead Sponsor
Graduate School of Pharmaceutical Sciences Takasaki University of Health and Welfare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are judged as being inappropriate for this study by their medical doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of gene expression and correlation between each genes expression in cancer tissues and normal tissues of patients with liver cancer and bile duct cancer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath